Myomo Inc - Asset Resilience Ratio
Myomo Inc (MYO) has an Asset Resilience Ratio of 11.70% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Myomo Inc (MYO) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Myomo Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see MYO asset base.
Liquid Assets Composition Over Time
This chart breaks down Myomo Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Myomo Inc (MYO) investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $4.30 Million | 11.7% |
| Total Liquid Assets | $4.30 Million | 11.70% |
Asset Resilience Insights
- Moderate Liquidity: Myomo Inc has 11.70% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Myomo Inc Industry Peers by Asset Resilience Ratio
Compare Myomo Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
TransMedics Group Inc
NASDAQ:TMDX |
Medical Devices | 0.00% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581 |
Medical Devices | 18.80% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273 |
Medical Devices | 34.29% |
Annual Asset Resilience Ratio for Myomo Inc (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Myomo Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 47.61% | $18.39 Million | $38.64 Million | -11.25pp |
| 2024-12-31 | 58.86% | $24.87 Million | $42.24 Million | -1.94pp |
| 2023-12-31 | 60.80% | $8.87 Million | $14.58 Million | +8.20pp |
| 2022-12-31 | 52.61% | $5.35 Million | $10.16 Million | -24.65pp |
| 2021-12-31 | 77.25% | $15.52 Million | $20.10 Million | -5.97pp |
| 2020-12-31 | 83.22% | $12.24 Million | $14.71 Million | +15.55pp |
| 2019-12-31 | 67.67% | $4.47 Million | $6.60 Million | -11.31pp |
| 2018-12-31 | 78.98% | $6.54 Million | $8.28 Million | -13.75pp |
| 2017-12-31 | 92.73% | $12.96 Million | $13.97 Million | +44.66pp |
| 2016-12-31 | 48.07% | $797.17K | $1.66 Million | -- |
About Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.… Read more